A new scientific statement from the American Heart Association on the postthrombotic syndrome offers evidence-based prevention, diagnosis, and treatment strategies for inpatient and outpatient care.
30 Sep 2014
Dual antiplatelet therapy may be safer than triple therapy in older patients with acute MI, afib after PCI
Older patients with acute myocardial infarction and atrial fibrillation who have undergone percutaneous coronary intervention appear to have a higher risk for major bleeding, both early and long-term, with triple therapy versus dual antiplatelet therapy.
4 Aug 2015
A 32-year-old woman is evaluated for a painful rash occurring bilaterally on her lower extremities, which began 2 days ago. She was admitted to the hospital 5 days ago for diagnosis and treatment of pulmonary embolism with heparin and warfarin. Her father had a pulmonary embolism after a long airplane ride. Following a physical exam and lab studies, what is the most likely diagnosis?
1 Feb 2019
The American Heart Association/American Stroke Association last week released updated guidelines on the primary prevention of stroke that included new recommendations on the use of statins, blood pressure management, and risk stratification for atrial fibrillation.
4 Nov 2014
Fondaparinux was associated with lower risk of major bleeding and death than low-molecular-weight heparin (LMWH) for patients with non-ST-segment elevation myocardial infarction (NSTEMI), a recent prospective study found.
24 Feb 2015
Differences in clinical presentation affect the timely identification, testing, and management of ischemic symptoms, leading to misdiagnosis, delayed revascularization, and higher acute myocardial infarction mortality rates.
2 Feb 2016
The makers of dabigatran allegedly failed to share information with regulators that would make using the drug safer—specifically, that monitoring plasma levels of the drug and adjusting doses accordingly could significantly reduce major bleeding, a new BMJ investigation found.
29 Jul 2014
Additional heart rhythm monitoring after cryptogenic stroke helped detect atrial fibrillation in 2 new studies published last week in the New England Journal of Medicine.
1 Jul 2014
Rivaroxaban has similar safety, efficacy versus warfarin in older and younger nonvalvular afib patients
Rivaroxaban appears to have similar safety and efficacy compared with warfarin in both older and younger patients with nonvalvular atrial fibrillation, although stroke and major bleeding rates were higher in the former group, a new study found.
10 Jun 2014
A 53-year-old woman is evaluated for a slowly enlarging, telangiectatic, pearly, ulcerated 1-cm plaque on the left temple. It bleeds periodically when traumatized. Medical history is significant for atrial fibrillation. She takes warfarin daily. She is otherwise in good health. Following a physical exam, cardiac exam, and biopsy of the lesion, what is the most appropriate treatment for this lesion?
26 Jan 2016